SI2389166T1 - Farmacevtski sestavek, ki obsega aleglitazar - Google Patents
Farmacevtski sestavek, ki obsega aleglitazarInfo
- Publication number
- SI2389166T1 SI2389166T1 SI201030129T SI201030129T SI2389166T1 SI 2389166 T1 SI2389166 T1 SI 2389166T1 SI 201030129 T SI201030129 T SI 201030129T SI 201030129 T SI201030129 T SI 201030129T SI 2389166 T1 SI2389166 T1 SI 2389166T1
- Authority
- SI
- Slovenia
- Prior art keywords
- aleglitazar
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09151254 | 2009-01-23 | ||
EP10701340A EP2389166B1 (en) | 2009-01-23 | 2010-01-13 | Pharmaceutical composition comprising aleglitazar |
PCT/EP2010/050343 WO2010084066A1 (en) | 2009-01-23 | 2010-01-13 | Pharmaceutical composition comprising aleglitazar |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2389166T1 true SI2389166T1 (sl) | 2013-02-28 |
Family
ID=42112184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201030129T SI2389166T1 (sl) | 2009-01-23 | 2010-01-13 | Farmacevtski sestavek, ki obsega aleglitazar |
Country Status (25)
Country | Link |
---|---|
US (2) | US20100190835A1 (sl) |
EP (1) | EP2389166B1 (sl) |
JP (1) | JP5619027B2 (sl) |
KR (2) | KR20140002812A (sl) |
CN (1) | CN102292074B (sl) |
AR (1) | AR075041A1 (sl) |
AU (1) | AU2010206249B2 (sl) |
BR (1) | BRPI1007237B1 (sl) |
CA (1) | CA2748896C (sl) |
CL (1) | CL2011001777A1 (sl) |
CY (1) | CY1113641T1 (sl) |
DK (1) | DK2389166T3 (sl) |
ES (1) | ES2397558T3 (sl) |
HR (1) | HRP20130108T1 (sl) |
IL (1) | IL213671A (sl) |
MX (1) | MX2011007381A (sl) |
PE (2) | PE20120421A1 (sl) |
PL (1) | PL2389166T3 (sl) |
PT (1) | PT2389166E (sl) |
RU (1) | RU2537224C2 (sl) |
SG (1) | SG173058A1 (sl) |
SI (1) | SI2389166T1 (sl) |
TW (1) | TWI406861B (sl) |
WO (1) | WO2010084066A1 (sl) |
ZA (1) | ZA201104670B (sl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013181384A1 (en) | 2012-05-31 | 2013-12-05 | Ratiopharm Gmbh | Solid state forms of aleglitazar sodium |
WO2014016371A1 (en) | 2012-07-27 | 2014-01-30 | Ratiopharm Gmbh | Micronized aleglitazar |
WO2014016369A1 (en) | 2012-07-27 | 2014-01-30 | Ratiopharm Gmbh | Pharmaceutical formulation comprising aleglitazar and complexing agent |
WO2014016370A1 (en) * | 2012-07-27 | 2014-01-30 | Ratiopharm Gmbh | Amorphous aleglitazar |
EP2895469B1 (en) * | 2012-09-12 | 2017-10-18 | F. Hoffmann-La Roche AG | Solid forms of (s)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzo[b]thiophen-7-yl}-propionic acid and of salts thereof |
BR112019002007B1 (pt) | 2016-08-10 | 2024-01-16 | F. Hoffmann-La Roche Ag | Composição farmacêutica e uso de uma composição farmacêutica |
CN114404375B (zh) * | 2022-01-21 | 2023-06-27 | 武汉九珑人福药业有限责任公司 | 一种叶酸固体制剂及其原料组合物、制备方法和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
AU2002342244B2 (en) * | 2001-05-15 | 2005-06-16 | F. Hoffmann-La Roche Ag | Carboxylic acid substituted oxazole derivatives for use as PPAR-alpha and -gamma activators in the treatment of diabetes |
GB0303600D0 (en) * | 2003-02-17 | 2003-03-19 | Glaxo Group Ltd | Novel therapeutic method and compositions |
US7262303B2 (en) * | 2003-09-29 | 2007-08-28 | Hoffman-La Roche Inc. | Process for the production of chiral propionic acid derivatives |
US20060051413A1 (en) * | 2004-09-08 | 2006-03-09 | Chow Sing S M | Method of enhancing absorptions of transmucosal administration formulations |
UA90708C2 (ru) * | 2005-02-25 | 2010-05-25 | Ф. Хоффманн-Ля Рош Аг | Таблетки с улучшенной дисперсностью лекарственного вещества |
US20060270722A1 (en) * | 2005-05-31 | 2006-11-30 | Thornberry Nancy A | Combination of a dipeptidyl peptidase-IV inhibitor and a dual PPAR agonist for the treatment of diabetes and obesity |
FR2894477A1 (fr) * | 2005-12-13 | 2007-06-15 | Galderma Res & Dev | Utilisation du naveglitazar pour la preparation d'une composition pharmaceutique destinee au traitement des affections dermatologiques |
US20100210692A1 (en) * | 2007-03-28 | 2010-08-19 | Farmer Stephen R | Methods of treatment using sirt modulators and compositions containing sirt1 modulators |
-
2010
- 2010-01-13 SI SI201030129T patent/SI2389166T1/sl unknown
- 2010-01-13 PE PE2011001309A patent/PE20120421A1/es not_active Application Discontinuation
- 2010-01-13 PL PL10701340T patent/PL2389166T3/pl unknown
- 2010-01-13 WO PCT/EP2010/050343 patent/WO2010084066A1/en active Application Filing
- 2010-01-13 AU AU2010206249A patent/AU2010206249B2/en not_active Ceased
- 2010-01-13 PT PT107013401T patent/PT2389166E/pt unknown
- 2010-01-13 PE PE2016000386A patent/PE20160746A1/es unknown
- 2010-01-13 SG SG2011052305A patent/SG173058A1/en unknown
- 2010-01-13 MX MX2011007381A patent/MX2011007381A/es active IP Right Grant
- 2010-01-13 DK DK10701340.1T patent/DK2389166T3/da active
- 2010-01-13 JP JP2011546748A patent/JP5619027B2/ja not_active Expired - Fee Related
- 2010-01-13 CA CA2748896A patent/CA2748896C/en not_active Expired - Fee Related
- 2010-01-13 KR KR1020137032602A patent/KR20140002812A/ko not_active Application Discontinuation
- 2010-01-13 CN CN2010800050015A patent/CN102292074B/zh not_active Expired - Fee Related
- 2010-01-13 RU RU2011134964/15A patent/RU2537224C2/ru not_active IP Right Cessation
- 2010-01-13 EP EP10701340A patent/EP2389166B1/en not_active Not-in-force
- 2010-01-13 KR KR1020117016128A patent/KR20110105798A/ko active Application Filing
- 2010-01-13 BR BRPI1007237-3A patent/BRPI1007237B1/pt not_active IP Right Cessation
- 2010-01-13 ES ES10701340T patent/ES2397558T3/es active Active
- 2010-01-19 US US12/689,296 patent/US20100190835A1/en not_active Abandoned
- 2010-01-21 AR ARP100100131A patent/AR075041A1/es not_active Application Discontinuation
- 2010-01-22 TW TW099101817A patent/TWI406861B/zh not_active IP Right Cessation
-
2011
- 2011-06-20 IL IL213671A patent/IL213671A/en unknown
- 2011-06-23 ZA ZA2011/04670A patent/ZA201104670B/en unknown
- 2011-07-22 CL CL2011001777A patent/CL2011001777A1/es unknown
-
2012
- 2012-11-12 US US13/674,310 patent/US20130072529A1/en not_active Abandoned
- 2012-12-03 CY CY20121101181T patent/CY1113641T1/el unknown
-
2013
- 2013-02-07 HR HRP20130108AT patent/HRP20130108T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1231408A1 (zh) | 藥物組合物 | |
HRP20161617T1 (hr) | Čvrsti farmaceutski sastav koji sadrži rivaroksaban | |
HK1217301A1 (zh) | 藥物組合物 | |
IL228817A0 (en) | Pharmaceutical compounds | |
EP2451274A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
EP2379077A4 (en) | PHARMACEUTICAL COMPOSITION | |
IL220097A (en) | Pharmaceutical preparation containing oligopeptides | |
ZA201104670B (en) | Pharmaceutical composition comprising aleglitazar | |
IL208387A0 (en) | Pharmaceutical composition | |
ZA201006224B (en) | Pharmaceutical composition | |
GB2464200B (en) | Pharmaceutical composition | |
EP2488175A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
GB0919650D0 (en) | Pharmaceutical composition | |
GB0817969D0 (en) | Pharmaceutical composition | |
HU0900010D0 (en) | Improved pharmaceutical composition | |
HU0800741D0 (en) | Improved pharmaceutical composition | |
GB0817974D0 (en) | Pharmaceutical composition | |
GB0817566D0 (en) | Pharmaceutical composition | |
GB0901241D0 (en) | Pharmaceutical compositions |